29 related articles for article (PubMed ID: 12894551)
1. Early and delayed castrations confer a similar survival advantage in TRAMP mice.
Zhang ZX; Xu QQ; Huang XB; Zhu JC; Wang XF
Asian J Androl; 2009 May; 11(3):291-7. PubMed ID: 19398956
[TBL] [Abstract][Full Text] [Related]
2. Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model.
Raina K; Kandhari K; Jain AK; Ravichandran K; Maroni P; Agarwal C; Agarwal R
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077751
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Prostate Tumor Development by Stimulation of Antitumor Immunity Using a Standardized Herbal Extract (Deep Immune®) in TRAMP Mice.
Liang P; Guo J; Li S; Guan Q; Vanderheyden T; So A; Wang Y; Chen T; Du C
Evid Based Complement Alternat Med; 2018; 2018():9707543. PubMed ID: 29861778
[TBL] [Abstract][Full Text] [Related]
4. Extremely Early Diagnostic Test for Prostate Cancer.
James VJ
J Cancer Ther; 2011 Aug; 2(3):377-380. PubMed ID: 22206041
[TBL] [Abstract][Full Text] [Related]
5. A C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor.
Raskatov JA; Puckett JW; Dervan PB
Bioorg Med Chem; 2014 Aug; 22(16):4371-5. PubMed ID: 24780272
[TBL] [Abstract][Full Text] [Related]
6. False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models.
Lawrence MD; Blyth BJ; Ormsby RJ; Tilley WD; Sykes PJ
Transgenic Res; 2013 Oct; 22(5):1037-47. PubMed ID: 23423848
[TBL] [Abstract][Full Text] [Related]
7. S100A9 interaction with TLR4 promotes tumor growth.
Källberg E; Vogl T; Liberg D; Olsson A; Björk P; Wikström P; Bergh A; Roth J; Ivars F; Leanderson T
PLoS One; 2012; 7(3):e34207. PubMed ID: 22470535
[TBL] [Abstract][Full Text] [Related]
8. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
[TBL] [Abstract][Full Text] [Related]
9. A review of the existing grading schemes and a proposal for a modified grading scheme for prostatic lesions in TRAMP mice.
Berman-Booty LD; Sargeant AM; Rosol TJ; Rengel RC; Clinton SK; Chen CS; Kulp SK
Toxicol Pathol; 2012; 40(1):5-17. PubMed ID: 22021166
[TBL] [Abstract][Full Text] [Related]
10. Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.
Martiniello-Wilks R; Dane A; Mortensen E; Jeyakumar G; Wang XY; Russell PJ
Anticancer Res; 2003; 23(3B):2633-42. PubMed ID: 12894551
[TBL] [Abstract][Full Text] [Related]
11. Androgen-independent prostate cancer progression in the TRAMP model.
Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
Wikström P; Lindahl C; Bergh A
Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
[TBL] [Abstract][Full Text] [Related]
13. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Yeh IT; Reddick RL; Kumar AP
Prostate; 2009 May; 69(7):755-60. PubMed ID: 19170049
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
